Marina Serper, MD, MS
@serperm
Followers
2K
Following
6K
Media
117
Statuses
2K
Liver disease/transplant. HSR/Epi. Telehealth, behavioral nudges, QI; cognition, aging, @penngihep @PennMedicine, @PennCHIBE, @PennLDI. Wife, mom, academic.
Philadelphia, PA
Joined September 2012
🏠New concept: Hepatology@Home Delivering expert care to complex patients in the community: Ascitic taps, LVP, antibiotics, diuretics. ✅Feasible ✅Safe ✅Avoids admission It's been v inspiring to watch @TamCarg grow this service from nothing👏 @ebtapper @serperm @NnekaUfereMD
Hep@home: management of patients with liver disease at home @FrontGastro_BMJ @UKHaHSoc @DanLasserson @BryonyRChapman @Dr_Sam_Mills @SophieMcGlen @esaunsbury
3
9
28
Thank you @AASLDFoundation and #AnnaLok for supporting my transition from fellowship to faculty. This award will be essential in my journey to become a physician-scientist!
👏 Congratulations to Pedro Ochoa-Allemant of the University of Pennsylvania for receiving the 2025 #AASLDFoundation Anna S. Lok Advanced/Transplant #Hepatology Fellow Award!
8
4
44
Check out new research by LDI Fellow Marina Serper (@serperM) on outcomes across steatotic liver disease subtypes. ⤵️
Patients with metabolic dysfunction and alcohol-associated liver disease and alcohol-associated liver disease have modestly higher risks of major adverse liver outcomes and all-cause mortality compared to those with MASLD. https://t.co/T1pGSbZOy0
0
2
7
Incredible innovations will bring more organ transplants to more people and those organs will be able to travel further and function better. Congratulations to Drs Shaver, Bacchetta, Griesemer and Zuckermann. @ttsorg @VUMChealth
https://t.co/61hYOvoUxd
thelancet.com
The large deficit in donated organs required to provide transplantation to patients with end-stage organ disease is a global health crisis, exacerbated by regional differences in clinical practice...
0
1
10
Advances in precision immunosuppression will protect transplant recipients from immunosuppression’s toxicities. When the organ does suffer injury, new deep phenotyping tools will tell us why. Congratulations to Alex Loupy, Marta Sablik and Kiran Khush.
thelancet.com
Transplant medicine faces substantial challenges, as patients require lifelong immunosuppression to prevent graft rejection. Immunosuppressive regimens to date, while reasonably effective at preven...
0
2
16
The field of transplant should commit to making this amazing therapy available to all who need it. Congratulations to Drs Jauré, Jha, McElroy, Muller, Oniscu, Serper, Purnell and Scholes-Robertson. @ESOTtransplant @AST_info
https://t.co/4yfdwzJ6Yr
thelancet.com
Advances in solid organ transplantation, such as improved organ preservation technologies and novel approaches to immunosuppression management, have the potential to improve outcomes in transplant...
0
5
15
Don’t miss @kymwatt, as she breaks down key findings from the #HEPATOLOGY article: “Determining a Safe Washout Period for Immune Checkpoint Inhibitors Prior to Liver Transplantation.” #LiverX
https://t.co/6LADRFEyd8
0
6
19
1/ Do clinical outcomes differ across steatotic liver disease subtypes? In @JAMAInternalMed, we report the incidence of adverse liver outcomes, cardiovascular events, and all-cause mortality across MASLD, MetALD, and ALD @RhubbBstat @KaplanDeLiver @SerperM ⬇️
Patients with metabolic dysfunction and alcohol-associated liver disease and alcohol-associated liver disease have modestly higher risks of major adverse liver outcomes and all-cause mortality compared to those with MASLD. https://t.co/T1pGSbZOy0
2
10
27
Balancing abstinence and harm reduction in ALD in the transplant continuum: An important perspective from Sue Hyon Kim @PennNursing and Sasha-Deutsch Link at UNC. @LTxJournal
https://t.co/yOBkpxbKX5
pubmed.ncbi.nlm.nih.gov
Alcohol use following liver transplantation (LT) is associated with worse outcomes. Strategies for predicting, preventing, and managing alcohol consumption among candidates and recipients of LT with...
1
0
3
I just learned that our letter to the editor is about one of TWO NEJM articles in 2025 that says naltrexone is contraindicated in cirrhosis There is no evidence for this claim We all need to be the change and make progress together.
Naltrexone is not contraindicated in cirrhosis There is no evidence of harm Only evidence of benefit Do we know for certain it is safe in Child C cirrhosis? No! Nothing is certain in child C cirrhosis.
7
9
53
1/🚨Check out our new study in @JHepatology❗️ Using natural language processing to identify >350,000 patients with #steatosis, we demonstrated that cause-specific mortality differs between #MASLD, #MetALD, and #ALD
#LiverTwitter #LiverX @PennGiHep
https://t.co/3Xszlm09mq
pubmed.ncbi.nlm.nih.gov
Causes of death across the steatotic liver disease (SLD) spectrum remain incompletely characterized in routine clinical settings. In this large nationwide cohort study, we evaluated cause-specific...
2
9
36
Thought provoking debate: Are you pro-AI vs pro-MELD for organ allocation? https://t.co/sScVMIoLeY
https://t.co/vaoEoRVIUK
#Livertwitter
0
11
14
How reversible is hepatic encephalopathy after all In some cases, the damage persists Important paper: https://t.co/qIG4SfgE62 Hey, @serperm, maybe we should work on preventing HE?
0
26
92
Very important work from @LaurenNephewMD on barriers faced by marginalized individuals for curative HCC Tx. @serperm @theNCI @ebtapper @fahisakanwal
🌟 Check out @LaurenNephewMD’s paper on barriers marginalized groups face in accessing curative treatments for hepatocellular carcinoma (#HCC), highlighting the need for more inclusive healthcare. 🤝 #LiverTwitter #ManuscriptMonday
https://t.co/VWYtqk92qZ
0
4
17
Thank you @CU_Transplant for this amazing opportunity. Enjoyed presenting my research, making new friends, meeting awesome faculty, and hearing about many controversial topics in transplant! Wouldn't be possible without @nadimmahmud @serperm @penngihep
Big shoutout to the young investigators who presented their research at Controversies in Transplantation! Your passion and dedication are driving the future of transplantation forward. Keep up the great work!
0
2
8
Lower child opportunity index is associated with increased healthcare utilization following pediatric liver transplantation @penngihep @serperm
https://t.co/q9foZh9w5Q
journals.lww.com
erminants of health and health care utilization among children (<18 y old at the time of LT) who have undergone LT, we performed a retrospective study merging data from the Organ Procurement and...
2
2
2
You're invited to join global experts in multidisciplinary discussions to advance the science and care of alcohol-associated liver disease (ALD). Sign up to attend the ALD-ALLY Conference and deep dive into the latest developments concerning ALD at https://t.co/m04P8Zzf6C.
0
2
10
Data on the bugs that cause SBP is so old UNTIL NOW! Thank you @nadimmahmud Varies with Child Class. Staph is climbing the charts! https://t.co/SqpCsMdqiD
1
27
91